Gerald L. Ray & Associates’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-13,800	Closed	-$233K	–	302
2016 Q1	$233K	Buy	+13,800	New	+$233K	0.04%	273